In the preceding three months, 5 analysts have released ratings for Leidos Holdings (NYSE:LDOS), presenting a wide array of perspectives from bullish to bearish.The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past ... Read more
Benzinga - Sep 24
During the last three months, 7 analysts shared their evaluations of Halozyme Therapeutics (NASDAQ:HALO), revealing diverse outlooks from bullish to bearish.The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them... Read more
Benzinga - Aug 18
